Inhibition of hepatic and intestinal CYP3A4 by mibefradil measured by the erythromycin breath test (EBT) and oral midazolam pharmacokinetics (PK)

Clinical Pharmacology and Therapeutics

Volumn 65, Issue 2, 1999, Pages 131-

  Veronese, M L ^a   Gillen, L P ^a   Dorval, E P ^a   Hauck, W W ^a   Waldman, S A ^a   Greenberg, H E ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001558755     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(99)80058-7     Document Type: Article

References (0)